Clinical Trial: SGB for COVID-induced Parosmia
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: COVID-19-Induced Parosmia
Study Type: INTERVENTIONAL
Official Title: Stellate Ganglion Block for the Treatment of COVID-19-Induced Parosmia: Double-Blinded, Placebo-Controlled Randomized Clinical Trial
Brief Summary:
Chronic olfactory dysfunction, both hyposmia and parosmia, from the COVID-19 pandemic is a growing public health crisis with up to 1.2 million people in the United States affected.Olfactory dysfunction impacts one's quality of life significantly by decreasing the enjoyment of foods, creating environmental safety concerns, and affecting one's ability to perform certain jobs.Olfactory loss is also an independent predictor of anxiety, depression, and even mortality.Recent research by our group (unpublished…
Read more